KH-type splicing regulatory protein controls colorectal cancer cell growth and modulates the tumor microenvironment
F. Caiazza, K. Oficjalska, M. Tosetto, J. Phelan, S. Noonan, P. Martin, K. Killick, L. Breen, F. O'Neill, B. Nolan, S. Furney, R. Power, D. Fennelly, C. Craik, J. O'Sullivan, K. Sheahan, G. Dohery, E. Ryan
Abstract
KH-type splicing regulatory protein (KHSRP) is a multifunctional nucleic acid binding protein implicated in key aspects of cancer cell biology: inflammation and cell-fate determination. However, the role KHSRP plays in colorectal cancer (CRC) tumorigenesis remains largely unknown. Using a combination of in silico analysis of large datasets, ex vivo analysis of protein expression in patients, and mechanistic studies using in vitro models of CRC, we investigated the oncogenic role of KHSRP. We demonstrated KHSRP expression in the epithelial and stromal compartments of both primary and metastatic tumors. Elevated expression was found in tumor versus matched normal tissue, and we validated these findings in larger independent cohorts in silico. KHSRP expression was a prognostic indicator of worse overall survival (HR=3.74, 95% CI = 1.43-22.97, p=0.0138). Mechanistic data in CRC cell line models supported a role of KHSRP in driving epithelial cell proliferation in both a primary and metastatic setting, through control of the G1/S transition. Additionally, KHSRP promoted a pro-angiogenic extracellular environment by regulating the secretion of oncogenic proteins involved in diverse cellular processes such as migration and response to cellular stress. Our study provides novel mechanistic insight into the tumor-promoting effects of KHSRP in CRC.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Post-transcriptional control of SRSF9 promotes the epithelial-to-mesenchymal transition (EMT) in colorectal cancer cells
C. Rao, R. A. Svoboda, … R. E. Lewis·bioRxiv·May 16, 2022
- E3 ubiquitin-ligase Hakai induces LRP4 degradation and regulates Wnt/beta-catenin signalling in colorectal cancer cells
Andrea Rodríguez-Alonso, Lía Jove, … Angélica Figueroa·bioRxiv·Nov 20, 2025
- In Silico study of clinical implication of markers associated with PTHrP regulatory mechanisms and linked to angiogenesis and EMT program of colorectal cancer
Pedro Carriere, María Belén Novoa Díaz, … Claudia Gentili·bioRxiv·Apr 20, 2026
- RIP140 regulates HES1 oscillatory expression and mitogenic activity in colon cancer cells
N. Sfeir, M. Kajdan, … V. Cavailles·bioRxiv·May 13, 2023
- RAS specific protease Induces Irreversible Growth Arrest via p27 in several KRAS Mutant Colorectal Cancer cell lines
C. K. Stubbs, M. Biancucci, … K. J. F. Satchell·bioRxiv·Dec 8, 2020
- HSF4: A Prognostic Predictor and Potential Therapeutic Target in Colorectal Cancer with Implications for Patient Immune Status
Ting Wan, Jun Tian Wu, … Jinghua Liu·bioRxiv·Jun 25, 2025